Prevalence of resistance to three fluoroquinolones : Assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility
More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to levofloxacin, ofloxacin, D-ofloxacin, and ciprofloxacin. Levofloxacin was confirmed to be twice as activ...
Gespeichert in:
Veröffentlicht in: | Antimicrobial agents and chemotherapy 1996, Vol.40 (7), p.1633-1639 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1639 |
---|---|
container_issue | 7 |
container_start_page | 1633 |
container_title | Antimicrobial agents and chemotherapy |
container_volume | 40 |
creator | FUCHS, P. C BARRY, A. L BROWN, S. D |
description | More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to levofloxacin, ofloxacin, D-ofloxacin, and ciprofloxacin. Levofloxacin was confirmed to be twice as active as ofloxacin and to have activity comparable to that of ciprofloxacin, with minor variations in activity against some species. The prevalence of resistant isolates was 7.1% to levofloxacin, 9.3% to ciprofloxacin, and 11.2% to ofloxacin. The susceptibilities of some species to the quinolones were less than those reported in previous studies. Pseudomonas aeruginosa isolates had the greatest variability in their susceptibilities to the three drugs between the participating centers. Two proposed zone size breakpoints for levofloxacin disk tests yielded similar low error rates. Ofloxacin and ciprofloxacin susceptibility test results correlated reasonably well with those of levofloxacin and could be used as surrogate indicators of levofloxacin susceptibility, but that resulted in some serious errors, and thus, direct testing of levofloxacin susceptibility is preferable. Replicate testing of standard quality control strains confirmed the established and proposed quality control parameters for all three quinolones tested. |
doi_str_mv | 10.1128/aac.40.7.1633 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_proquest_miscellaneous_15592146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15592146</sourcerecordid><originalsourceid>FETCH-LOGICAL-g238t-8270d6b54a9bc4cef67b9d95f97dd6c3cb7bef36db8ca55aa891465a99b6f8f23</originalsourceid><addsrcrecordid>eNplkDFvFDEQhS0EEkegpHeB0u3FXq-9Nl0UJRApUlJAfZr1joPBtz483oj8GP5rfEq6VKNv9N7ovWHssxRbKXt7BuC3g9iOW2mUesM2UjjbGe3MW7YRwphusGJ4zz4Q_RaNtRMb9v-u4AMkXDzyHHhBilThSDXz-qsg8pDWXPLfNS455QWJf-XnREi0x6UeTQkfckj5H_i48DnSH16RKsdScuEFGnBYZk5rW9w35IeCc_Q1F3plp5U8HmqcYor18SN7FyARfnqZJ-zn1eWPi-_dze2364vzm-6-V7Z2th_FbCY9gJv84DGYcXKz08GN82y88tM4YVBmnqwHrQGsk4PR4Nxkgg29OmGnz3cPx6It_G4fW46UYMG80k5q7fpmacIvL0IgDymU9qpIu0OJeyiPOyWVtH2vngDvfn7b</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15592146</pqid></control><display><type>article</type><title>Prevalence of resistance to three fluoroquinolones : Assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>FUCHS, P. C ; BARRY, A. L ; BROWN, S. D</creator><creatorcontrib>FUCHS, P. C ; BARRY, A. L ; BROWN, S. D</creatorcontrib><description>More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to levofloxacin, ofloxacin, D-ofloxacin, and ciprofloxacin. Levofloxacin was confirmed to be twice as active as ofloxacin and to have activity comparable to that of ciprofloxacin, with minor variations in activity against some species. The prevalence of resistant isolates was 7.1% to levofloxacin, 9.3% to ciprofloxacin, and 11.2% to ofloxacin. The susceptibilities of some species to the quinolones were less than those reported in previous studies. Pseudomonas aeruginosa isolates had the greatest variability in their susceptibilities to the three drugs between the participating centers. Two proposed zone size breakpoints for levofloxacin disk tests yielded similar low error rates. Ofloxacin and ciprofloxacin susceptibility test results correlated reasonably well with those of levofloxacin and could be used as surrogate indicators of levofloxacin susceptibility, but that resulted in some serious errors, and thus, direct testing of levofloxacin susceptibility is preferable. Replicate testing of standard quality control strains confirmed the established and proposed quality control parameters for all three quinolones tested.</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.40.7.1633</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Antimicrobial agents and chemotherapy, 1996, Vol.40 (7), p.1633-1639</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022,27921,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3131822$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>FUCHS, P. C</creatorcontrib><creatorcontrib>BARRY, A. L</creatorcontrib><creatorcontrib>BROWN, S. D</creatorcontrib><title>Prevalence of resistance to three fluoroquinolones : Assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility</title><title>Antimicrobial agents and chemotherapy</title><description>More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to levofloxacin, ofloxacin, D-ofloxacin, and ciprofloxacin. Levofloxacin was confirmed to be twice as active as ofloxacin and to have activity comparable to that of ciprofloxacin, with minor variations in activity against some species. The prevalence of resistant isolates was 7.1% to levofloxacin, 9.3% to ciprofloxacin, and 11.2% to ofloxacin. The susceptibilities of some species to the quinolones were less than those reported in previous studies. Pseudomonas aeruginosa isolates had the greatest variability in their susceptibilities to the three drugs between the participating centers. Two proposed zone size breakpoints for levofloxacin disk tests yielded similar low error rates. Ofloxacin and ciprofloxacin susceptibility test results correlated reasonably well with those of levofloxacin and could be used as surrogate indicators of levofloxacin susceptibility, but that resulted in some serious errors, and thus, direct testing of levofloxacin susceptibility is preferable. Replicate testing of standard quality control strains confirmed the established and proposed quality control parameters for all three quinolones tested.</description><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNplkDFvFDEQhS0EEkegpHeB0u3FXq-9Nl0UJRApUlJAfZr1joPBtz483oj8GP5rfEq6VKNv9N7ovWHssxRbKXt7BuC3g9iOW2mUesM2UjjbGe3MW7YRwphusGJ4zz4Q_RaNtRMb9v-u4AMkXDzyHHhBilThSDXz-qsg8pDWXPLfNS455QWJf-XnREi0x6UeTQkfckj5H_i48DnSH16RKsdScuEFGnBYZk5rW9w35IeCc_Q1F3plp5U8HmqcYor18SN7FyARfnqZJ-zn1eWPi-_dze2364vzm-6-V7Z2th_FbCY9gJv84DGYcXKz08GN82y88tM4YVBmnqwHrQGsk4PR4Nxkgg29OmGnz3cPx6It_G4fW46UYMG80k5q7fpmacIvL0IgDymU9qpIu0OJeyiPOyWVtH2vngDvfn7b</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>FUCHS, P. C</creator><creator>BARRY, A. L</creator><creator>BROWN, S. D</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>1996</creationdate><title>Prevalence of resistance to three fluoroquinolones : Assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility</title><author>FUCHS, P. C ; BARRY, A. L ; BROWN, S. D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g238t-8270d6b54a9bc4cef67b9d95f97dd6c3cb7bef36db8ca55aa891465a99b6f8f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FUCHS, P. C</creatorcontrib><creatorcontrib>BARRY, A. L</creatorcontrib><creatorcontrib>BROWN, S. D</creatorcontrib><collection>Pascal-Francis</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FUCHS, P. C</au><au>BARRY, A. L</au><au>BROWN, S. D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of resistance to three fluoroquinolones : Assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><date>1996</date><risdate>1996</risdate><volume>40</volume><issue>7</issue><spage>1633</spage><epage>1639</epage><pages>1633-1639</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>More than 3,000 consecutive clinical bacterial isolates from 10 U.S. medical centers were subjected to standard broth microdilution and disk diffusion tests to determine their susceptibilities to levofloxacin, ofloxacin, D-ofloxacin, and ciprofloxacin. Levofloxacin was confirmed to be twice as active as ofloxacin and to have activity comparable to that of ciprofloxacin, with minor variations in activity against some species. The prevalence of resistant isolates was 7.1% to levofloxacin, 9.3% to ciprofloxacin, and 11.2% to ofloxacin. The susceptibilities of some species to the quinolones were less than those reported in previous studies. Pseudomonas aeruginosa isolates had the greatest variability in their susceptibilities to the three drugs between the participating centers. Two proposed zone size breakpoints for levofloxacin disk tests yielded similar low error rates. Ofloxacin and ciprofloxacin susceptibility test results correlated reasonably well with those of levofloxacin and could be used as surrogate indicators of levofloxacin susceptibility, but that resulted in some serious errors, and thus, direct testing of levofloxacin susceptibility is preferable. Replicate testing of standard quality control strains confirmed the established and proposed quality control parameters for all three quinolones tested.</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><doi>10.1128/aac.40.7.1633</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial agents and chemotherapy, 1996, Vol.40 (7), p.1633-1639 |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_proquest_miscellaneous_15592146 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Medical sciences Pharmacology. Drug treatments |
title | Prevalence of resistance to three fluoroquinolones : Assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T16%3A13%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20resistance%20to%20three%20fluoroquinolones%20:%20Assessment%20of%20levofloxacin%20disk%20test%20error%20rates%20and%20surrogate%20predictors%20of%20levofloxacin%20susceptibility&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=FUCHS,%20P.%20C&rft.date=1996&rft.volume=40&rft.issue=7&rft.spage=1633&rft.epage=1639&rft.pages=1633-1639&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/aac.40.7.1633&rft_dat=%3Cproquest_pasca%3E15592146%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15592146&rft_id=info:pmid/&rfr_iscdi=true |